Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INMD NASDAQ:MDXG NASDAQ:RXST NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINMDInMode$14.51+0.7%$14.49$13.14▼$19.85$944.34M21.04 million shs678,489 shsMDXGMiMedx Group$7.10-1.3%$6.85$5.47▼$10.14$1.05B1.74528,930 shs448,680 shsRXSTRxSight$8.89+2.2%$8.95$6.32▼$57.53$369.88M1.181.22 million shs1.14 million shsTCMDTactile Systems Technology$13.24-1.6%$11.28$8.61▼$21.10$296.71M1.04249,940 shs232,912 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINMDInMode+0.69%-4.48%+3.13%+1.19%-7.70%MDXGMiMedx Group-1.25%-0.98%-0.70%+11.99%+11.29%RXSTRxSight+2.18%+3.98%+12.25%-40.42%-83.29%TCMDTactile Systems Technology-1.56%+0.68%+33.87%+30.96%-1.93%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINMDInMode3.1511 of 5 stars2.15.00.00.03.61.71.9MDXGMiMedx Group3.4447 of 5 stars3.52.00.00.03.61.71.9RXSTRxSight2.2788 of 5 stars3.03.00.00.02.41.70.6TCMDTactile Systems Technology2.33 of 5 stars1.22.00.00.03.02.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINMDInMode 2.13Hold$18.0424.34% UpsideMDXGMiMedx Group 3.00Buy$12.0069.01% UpsideRXSTRxSight 1.91Reduce$10.0012.49% UpsideTCMDTactile Systems Technology 2.40Hold$13.501.96% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, INMD, MDXG, and RXST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025RXSTRxSightUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$16.00 ➝ $8.008/8/2025RXSTRxSightStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$9.00 ➝ $8.008/8/2025RXSTRxSightNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$22.00 ➝ $11.008/5/2025TCMDTactile Systems TechnologyWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy8/5/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$12.00 ➝ $13.007/31/2025MDXGMiMedx GroupCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$11.00 ➝ $12.007/30/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold7/30/2025INMDInModeBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$24.00 ➝ $21.007/15/2025MDXGMiMedx GroupCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$11.007/15/2025RXSTRxSightMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$20.00 ➝ $9.007/11/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold$15.00(Data available from 9/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINMDInMode$394.82M2.32$1.77 per share8.19$9.94 per share1.46MDXGMiMedx Group$348.88M3.01$0.33 per share21.43$1.46 per share4.86RXSTRxSight$139.93M2.60N/AN/A$6.79 per share1.31TCMDTactile Systems Technology$292.98M1.01$1.08 per share12.30$8.74 per share1.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINMDInMode$181.27M$2.475.877.97N/A44.50%18.38%16.35%10/29/2025 (Estimated)MDXGMiMedx Group$42.42M$0.2133.8122.19N/A8.84%23.03%17.09%10/29/2025 (Estimated)RXSTRxSight-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6221.3515.76N/A5.06%7.72%5.59%11/3/2025 (Estimated)Latest TCMD, INMD, MDXG, and RXST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Guidance UpdateRXSTRxSight-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million8/4/2025Q2 2025TCMDTactile Systems Technology$0.09$0.14+$0.05$0.14$73.93 million$78.91 million7/30/2025Q2 2025INMDInMode$0.50$0.47-$0.03$0.42$98.45 million$95.60 million7/30/2025Q2 2025MDXGMiMedx Group$0.06$0.10+$0.04$0.06$90.79 million$98.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINMDInModeN/AN/AN/AN/AN/AMDXGMiMedx GroupN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINMDInModeN/A9.608.58MDXGMiMedx Group0.084.393.90RXSTRxSightN/A13.9312.70TCMDTactile Systems Technology0.113.793.36Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINMDInMode68.04%MDXGMiMedx Group79.15%RXSTRxSight78.78%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipINMDInMode6.92%MDXGMiMedx Group1.70%RXSTRxSight9.57%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINMDInMode48063.21 million58.84 millionOptionableMDXGMiMedx Group870147.96 million145.44 millionOptionableRXSTRxSight22040.92 million37.00 millionOptionableTCMDTactile Systems Technology1,03722.29 million21.74 millionOptionableTCMD, INMD, MDXG, and RXST HeadlinesRecent News About These CompaniesNuveen LLC Acquires New Holdings in Tactile Systems Technology, Inc. $TCMD2 hours ago | marketbeat.comCharles Schwab Investment Management Inc. Cuts Holdings in Tactile Systems Technology, Inc. $TCMDSeptember 3 at 3:19 AM | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives $13.50 Consensus Price Target from AnalystsSeptember 3 at 2:09 AM | americanbankingnews.comTactile Systems Technology, Inc. $TCMD Shares Sold by Paradigm Capital Management Inc. NYSeptember 2 at 8:33 AM | marketbeat.comRussell Investments Group Ltd. Trims Stock Holdings in Tactile Systems Technology, Inc. $TCMDSeptember 2 at 3:49 AM | marketbeat.comReturns At Tactile Systems Technology (NASDAQ:TCMD) Are On The Way UpSeptember 1 at 6:48 PM | finance.yahoo.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from BrokeragesSeptember 1 at 3:19 AM | marketbeat.comMartingale Asset Management L P Grows Stock Position in Tactile Systems Technology, Inc. $TCMDAugust 27, 2025 | marketbeat.comAre Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?August 22, 2025 | zacks.comTactile Systems Technology, Inc. $TCMD Shares Sold by Tocqueville Asset Management L.P.August 20, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) CEO Sheri Louise Dodd Sells 7,762 SharesAugust 14, 2025 | marketbeat.comKoss Olinger Consulting LLC Takes Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)August 11, 2025 | marketbeat.comBlair William & Co. IL Reduces Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)August 10, 2025 | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Upgraded by Wall Street Zen to Buy RatingAugust 10, 2025 | marketbeat.comWhat is B. Riley's Estimate for TCMD Q1 Earnings?August 8, 2025 | marketbeat.comQ3 Earnings Forecast for TCMD Issued By William BlairAugust 8, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from AnalystsAugust 7, 2025 | marketbeat.comWilliam Blair Upgrades Tactile Systems Technology (NASDAQ:TCMD) to Strong-BuyAugust 7, 2025 | marketbeat.comB. Riley Analysts Reduce Earnings Estimates for TCMDAugust 7, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comB. Riley Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock PriceAugust 6, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTCMD, INMD, MDXG, and RXST Company DescriptionsInMode NASDAQ:INMD$14.51 +0.10 (+0.69%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$14.57 +0.06 (+0.41%) As of 05:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.MiMedx Group NASDAQ:MDXG$7.10 -0.09 (-1.25%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$7.06 -0.04 (-0.56%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.RxSight NASDAQ:RXST$8.89 +0.19 (+2.18%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$8.88 -0.01 (-0.06%) As of 09/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Tactile Systems Technology NASDAQ:TCMD$13.24 -0.21 (-1.56%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$13.24 -0.01 (-0.04%) As of 09/3/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
